agilon health Q4 revenue up 49% to $690M; FY2022 Adjusted EBITDA turns positive; guides 2023 EBITDA $75-90M

agilon health, inc.

Q4 revenue $690M (+49% YoY); FY2022 revenue $2.71B (+48%). Medicare Advantage members 269,500 (+45%).
Q4 medical margin $61M (+93%); FY2022 medical margin $305M (+67%). Medical margin rate 8.8% Q4, 11.2% FY.
Q4 net loss $57M (flat YoY); FY2022 net loss $107M vs $407M (includes $292M non-cash stock comp in 2021).
FY2022 Adjusted EBITDA positive $4M vs negative $39M; Q4 Adjusted EBITDA negative $11M vs negative $27M.
Completed acquisition of mphrX on Feb 28, 2023; expects 2023 revenue $4.28-4.37B, Adjusted EBITDA $75-90M.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

agilon health, inc. reported the quarter ended December 31, 2022 results: revenue $690 million, net income Net loss of $57 million. Guidance initiated.

Period: the quarter ended December 31, 2022
Revenue: $690 million
Net income: Net loss of $57 million
Guidance: initiated
Result: reported results

Exact text from the filing

Total revenue of $690 million increased 49% during the fourth quarter compared to $463 million in the fourth quarter 2021.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

agilon health, inc. reported the fiscal year ended December 31, 2022 results: revenue $2.71 billion, net income Net loss of $107 million. Guidance initiated.

Period: the fiscal year ended December 31, 2022
Revenue: $2.71 billion
Net income: Net loss of $107 million
Guidance: initiated
Result: reported results

Exact text from the filing

For the fiscal year 2022, total revenue of $2.71 billion increased 48% compared to $1.83 billion in the comparable 2021 period.

View on SEC.gov

Browse all earnings releases →

agilon health, inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-005516

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.